The Clinical Sequencing and Evidence-Generating Research (CSER) Consortium is a federally-funded, multi-site research network studying the clinical utility of integrating genomic sequencing into practical healthcare.

For more information about CSER, please see the following links:

  1. National Human Genome Research Institute (NHGRI) CSER Homepage
  3. RFA-HG-16-011: Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites with Enhanced Diversity (U01)